In addition, this is the first study attempting to enumerate CECs and any subsets of CD34+/CD45- cells, deriving from several combination of endothelial markers (CD144, CD146 and CD309), by flow cytometry in the peripheral blood of CAD patients. The gene discussed is PTPRC; the disease is coronary artery disorder.